Description
FH535, soluble in warmed DMSO and insoluble in water and ethanol, disrupts the Wnt/β-catenin signaling pathway, a critical pathway in regulating cell fate, proliferation, and stem cell renewal, providing significant therapeutic prospects in cancer and fibrotic diseases by curbing abnormal cell growth and differentiation. It targets PPARδ, PPARγ, and Wnt/β-catenin.